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We previously demonstrated that cellular mRNAs are degraded in CD4 positive lymphocytes infected by the human
immunodeficiency virus, HIV-1, but not in cells infected by the simian lentivirus, SIV. To begin to define the molecular
mechanisms underlying this RNA degradation, we have established an in vitro RNA degradation assay utilizing extracts
from both infected and uninfected cells. We found that in vitro transcribed, 32P-radiolabeled actin RNA was degraded in
extracts prepared from CEM, CEMx174, and C8166 cells which were infected with HIV-1. Minimal actin RNA degradation
was observed in extracts prepared from uninfected cells. Similarly little degradation was observed in cell-free extracts
prepared from SIV-infected cells. To determine if viral RNA sequences could impart enhanced stability to cellular RNAs in
our in vitro assay, we prepared radiolabeled RNAs that contained selected viral RNA determinants. One such RNA contained
the HIV-1-specific TAR (transactivating region) sequence (nucleotides 1–111) appended to a reporter CAT RNA. Like the
cellular actin RNA, these TARCAT RNAs were degraded in HIV-1-infected cell extracts, but not in extracts from uninfected
cells or extracts prepared from SIV-infected cells. In contrast, an RNA containing only authentic HIV-1 sequences comprising
TAR and gag sequences was more stable than actin RNA in HIV-1-infected extracts. These results, taken together, suggest
that the in vitro assay reproduces events that occur in vivo and provide a starting point for identifying the factors responsible
for cellular RNA degradation in HIV-1-infected cells. q 1996 Academic Press, Inc.
INTRODUCTION lated mRNA degradation also is prevalent in nonviral
eukaryotic systems and is now recognized as playing
Both RNA and DNA eukaryotic viruses can have pro-
a major role in the control of cellular gene expression
foundly negative effects on host cell gene expression
(reviewed in Decker and Parker, 1994, and Beelman and
during infection (Carrasco, 1977; Schneider and Shenk, Parker, 1995).
1987; Katze and Agy, 1990; Garfinkel and Katze, 1993). Despite the substantial research focus on human im-
Virus infection may adversely effect cellular gene tran- munodeficiency virus type 1 (HIV-1), suprisingly little is
scription and can result in the inhibition of cellular mRNA known about the effects of HIV-1 infection on cellular
transport (Crawford et al., 1981; Babich et al., 1983). Alter- gene expression. Possible exceptions include studies on
natively, viruses can influence cytoplasmic events: for the HIV-1-induced downregulation of surface CD4 ex-
example, there is often a redirection from cellular to viral pression, a well understood phenomenon that is likely
mRNA translation resulting in the shutoff of cellular pro- caused, at least in part, by the nef and vpu regulatory
tein synthesis (Sonenberg, 1987; Mathews and Shenk, gene products (Willey et al., 1992; reviewed in Trono,
1990; Garfinkel and Katze, 1993, 1994). One of the most 1995). In addition, it was recently shown that the vpr
dramatic effects of virus infection is found in cells in- regulatory gene product can adversely effect the cell cy-
fected by herpes simplex virus (HSV). In HSV-infected cle (Levy et al., 1993, 1995; Heinzinger et al., 1994; Rogel
cells there is a marked reduction of cellular protein syn- et al., 1995). Previously we found that, similar to the situa-
thesis due primarily to cellular mRNA degradation (Fen- tion in HSV-infected cells, cellular protein synthesis is
wick and Clark, 1982; reviewed in Katze and Agy, 1990; inhibited in HIV-1-infected cells. This is not the result of
Krikorian and Read, 1991; Sorenson et al., 1991). This HIV-1-encoded translational control strategies, but rather
virion host shutoff (vhs) function, which induces both cel- is due to the degradation of cellular mRNAs (Agy et al.,
lular and HSV viral mRNA degradation is likely caused 1990). We subsequently observed that this cellular mRNA
by a virion structural component via as yet undefined degradation is specific for HIV-1 as no degradation was
mechanisms (Read and Frenkel, 1983; Oroskar and Read, observed in cells infected by the closely related simian
1989; Smibert et al., 1992; Pak et al., 1995). Indeed, regu- lentivirus, SIV (Agy et al., 1991).
In the present report, we established an in vitro mRNA
degradation assay to elucidate the mechanisms of mRNA1 To whom reprint requests should be addressed. Fax: (206) 685-
0305. E-mail: honey@u.washington.edu. degradation in HIV-1-infected cells. We found that a rep-
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resentative cellular mRNA, actin mRNA, was degraded were at least 90% infected and 85% viable. After each
wash, cells were pelleted at 1000 rpm for 5 min. Afterin extracts prepared from HIV-1-infected cells but not
in mock-infected cells. We also found that much less the last wash, the cells were permeabilized for 60 sec
in 5 ml wash buffer containing 200 mg/ml lysolecithindegradation occurred in extracts prepared from cells in-
fected with the simian lentivirus, SIV. These data suggest (L-a-lysophosphatidyl choline; Sigma) and then gently
pelleted (1000 rpm for 5 min). The cells were then resus-that the in vitro assay faithfully reproduced the events
that occur in vivo. Finally, efforts were made to determine pended in 1 ml standard reaction buffer [100 mM Hepes,
pH 7.4, 200 mM ammonium chloride, 20 mM magnesiumthe stability of mRNAs containing HIV-1-specific se-
quences in the in vitro mRNA degradation assay. acetate, 7 mM potassium chloride, 1 mM dithiothreitol,
1 mM ATP, 1 mM GTP, 40 mM 20 amino acids, 0.1 mM
s-adenosylmethionine, 1 mM spermidine, 10 mM cre-MATERIALS AND METHODS
atine phosphate (dipotassium salt), 40 U/ml creatine ki-
nase, 100 U/ml RNasin (Promega)] and were disruptedCells and virus. CD4-positive cells were maintained in
RPMI 1640 (Gibco-BRL) containing 10% heat-inactivated via 10 passages through a 25-gauge needle, and the
nuclei removed with a low-speed spin. The supernatantsfetal bovine serum. CEM, CEMx174, and C8166 were
obtained from the American Type Culture Collection and were stored in liquid nitrogen until used.
In vitro mRNA degradation assay. The degradationthe AIDS repository. sMAGI cells were obtained from
Bryce Chackerian and Julie Overbaugh and were main- assay was adapted from the method described by Kriko-
rian and Read (1991). Extracts were thawed on ice andtained as a monolayer in DMEM containing 10% fetal
bovine serum and 50 U/ml hygromycin (Calbiochem). RNasin added to 100 U/ml while thawing to prevent non-
specific degradation. A 50-ml sample was withdrawnHIV-1, strain LAI (Barre-Sinoussi et al., 1983; Wain-Hob-
son et al., 1991), was propagated on CEM cells as de- while the extracts were still on ice for the time zero point.
The extracts were incubated at 307C and 50-ml samplesscribed previously (Agy et al., 1990, 1991). The stock was
generated by infecting 5 1 107 cells with a multiplicity withdrawn at the indicated time points. All samples were
added to 250 ml of solution D [4 M guanidinium thiocya-of infection (m.o.i.) of 0.001 TCID50/cell. At Day 3, the
supernatant was replaced with 100 ml fresh medium. At nate (Fluka), 25 mM sodium citrate (pH 7), 0.5% sarcosyl,
0.1 M 2-mercaptoethanol] containing 10 mg tRNA carrierDay 4, the supernatant was collected and frozen. SIV
mac251 (Daniel et al., 1985) was propagated in MT4 cells and were stored at 0707C until processed.
Plasmid construction and transcription. A RNA expres-in a like manner. The E11S SIV/Mne virus stocks were
prepared by collecting culture supernatants from the sion vector (termed TARGAG) containing bona fide HIV-
1 sequences beginning with the/1 nucleotide containedchronically infected HUT 78 cell line. The resulting HIV
stocks were titrated by limiting dilution and added to the within the TAR region and extending through nucleotide
684 of the gag gene was constructed using PCR amplifi-cells for 1 hr at 377C at a m.o.i. of 0.01 TCID50/cell. The
cells were washed free of unattached virus and placed cation. The fragment was then directionally cloned into
the KpnI and BamHI sites of pBluescript-SK such thatin culture at 1 1 106 cells/ml. The resulting SIV stocks
were titrated on sMAGI cells as described previously RNA could be transcribed using the T7 promoter. Primers
were designed to include these restriction sites and are(Chackerian et al., 1995).
Indirect immunofluorescence assay. Suspension cells as follows: Kpn–TAR, ATAGGTACCGGGTCTCTCTGG-
TTAGACCA; GAG684–Bam, AAAGGATCCCATCTGGCC-were applied to glass slides, air-dried, fixed in a 1:1
methanol:acetone solution, and stored at 0207C until TGGTGCAATAG. Primers were obtained from Genosys
Biotechnologies. Sequencing was performed to verify thestained. The fixed cells were hydrated and nonspecific
binding sites blocked with 5% BSA in PBS solution. The construction. The actin and GAPDH plasmids were pur-
chased from American Type Culture Collection. Prior tocells were then incubated with pooled human sera from
HIV-1-infected patients or serum from an SIV-infected transcription, both plasmids were linearized with BamHI,
resulting in an RNA of approximately 1.1 kb for actin andmacaque, followed by an incubation with fluorescein
conjugated rabbit anti-human IgG (Dako). Cells were 1020 nucleotides for TARGAG. mRNA was transcribed
using T7 RNA polymerase under the following conditions:counterstained with 0.005% Evans blue in 1% BSA in PBS.
Cell-free extract preparation. Cells were counted, via- 4 mM DTT, 80 mg/ml BSA, 8 mM magnesium chloride, 1
U/ml RNasin, 0.5 mM ATP, 0.5 mM CTP, 0.3 mM UTP, 0.1bility ascertained, and extracts prepared following a pro-
tocol adapted from Brown et al. (1983) and Krikorian and mM GTP, 0.16 mM m7G(5*)ppp(5*)G, [32P]UTP, 2 U/ml T7
RNA polymerase at 307C for 75 min. The TARCAT plas-Read (1991). Approximately 108 cells were washed two
times with 40 ml ice-cold wash buffer (150 mM sucrose, mid, containing the TAR /1–111 sequences appended
to CAT mRNA, was a gift of Nahum Sonenberg (Parkin33 mM ammonium chloride, 7 mM potassium chloride,
4.5 mM magnesium acetate, 30 mM Hepes, pH 7.4). In et al., 1988) and was transcribed using the SP6 system
under similar conditions with the following changes: 5most cases extracts were prepared from cells which
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mM DTT, 0.2 mM UTP, 1.2 U/ml Sp6 RNA polymerase at hyde phosphate dehydrogenase (GAPDH) mRNAs. The
levels of actin and GAPDH mRNAs decreased at 3 and377C for 60 min. Runoff TARCAT transcripts were approxi-
mately 740 nucleotides. All transcripts were extracted 4 days post HIV-1-infection of CEM cells. This effect was
viral specific as no decrease in RNA levels was observedwith phenol/chloroform, ethanol precipitated, and resus-
pended in 25 ml H2O per reaction before use. in mock-infected cells. When this same blot was stripped
and reprobed with an HIV-specific probe, high amountsRNA preparation and gel electrophoresis. RNA was
prepared as described by Chomczynski and Sacchi of HIV RNAs were detected, confirming that these cells
were infected (Fig. 1C). Similar data were obtained with(1987). Radiolabeled RNAs were run on 5% acrylamide
gels containing 11 TBE and 7.5 M urea. Samples were HIV-1-infected C8166, CEMx174, and MT4 cells (data not
shown). Examination of the 18S and 28S ribosomal RNAsprepared in loading dye (80% formamide, 1 mM Pipes,
pH 6.8, 0.1 mM EDTA, xylene cyanol, bromophenol blue), in an ethidium bromide stained gel, revealed that ribo-
somal RNAs were not degraded in HIV-infected cells andboiled, and then loaded on prerun gels and the gels were
run overnight at 200 V in 11 TBE. Gels were dried and that equal quantities of RNA were loaded in each lane
(data not shown). In contrast to the situation with HIV-1,exposed to film and subsequently to phosphorimaging
screens. SIV mac251 did not induce decreases in cellular mRNA
levels (Fig 1B). No decreases in actin or GAPDH mRNANorthern blot analysis. RNA (5 mg) was electropho-
resed on 1% agarose (Seakem LE; FMC) gels containing levels were observed in SIV-infected cells even at 4 days
postinfection when 95% of cells were infected with SIV.11 Mops and 6.2% formaldehyde as earlier described
(Thomas, 1980). The gels were then blotted onto nitro- When this same blot was stripped and reprobed with
an SIV-specific probe, high amounts of SIV RNAs werecellulose filters in 201 SSC. The blots were prehybrid-
ized at 377C for at least 1 hr in 50% formamide, 50 mM detected, confirming that these cells were infected (Fig.
1D). These data, taken together, are consistent with ourHepes (pH 7.4), 31 Denhardt’s, 31 SSC, 0.1% sodium
dodecyl sulfate (SDS), and 100 mg/ml salmon sperm earlier work, demonstrating that cellular mRNAs are de-
graded only in cells infected by HIV-1.DNA. The prehybridization solution was replaced with
fresh solution and the boiled probe(s) added. The ARV Analysis of HIV-1-induced cellular mRNA degradation
in a cell-free system. We proceeded to determineHIV-1 and SIV BK28 plasmids were obtained from the
AIDS repository. All probes were prepared using the whether extracts prepared from HIV-1-infected CEM cells
caused the accelerated degradation of cellular mRNAsRandom Prime kit from Gibco-BRL and 32P-labeled dCTP
(Amersham). The probes were run over G50 Sephadex in vitro. We prepared extracts from cells which were
treated with the detergent lysolecithin to permeabilizecolumns before use.
Phosphorimager analysis. The dried gels were ex- the cells. This technique was originally utilized by Brown
et al. (1983) to prepare translationally active cell-free ex-posed to a phosphorimaging screen and the screen
scanned using Imagequant scanner and software. Identi- tracts. This particular approach was attractive for two
reasons. Most importantly, Krikorian and Read (1991)cal rectangles were placed exclusively around the major
intact full-length RNAs and the intensities quantitated for successfully used this procedure to study the in vitro
degradation of cellular and viral mRNAs in extracts pre-analysis of degradation.
pared from herpes simplex virus-infected cells. We also
favored this procedure because the use of detergent re-RESULTS
duced the biohazard risk associated with working with
the human and simian lentiviruses. We viewed this asHIV-1-induced cellular mRNA degradation in virus-in-
fected cells. Before establishing an in vitro system for advantageous despite the reported successes by Ross
and colleagues who utilized non-detergent-treated ex-mRNA degradation, it was essential to verify the degrada-
tion of cellular mRNAs in HIV-1-infected cells (Agy et al., tracts for their in vitro RNA degradation studies (Ross
and Kobs, 1986; Ross et al., 1987; Ross, 1988; Sorenson1990). At the same time, we wanted to extend our SIV
analysis by examining the possible degradation of cellu- et al., 1991).
In the initial series of experiments, we tested the stabil-lar mRNAs in CD4-positive cell lines infected by a simian
lentivirus more robust and cytopathic than our originally ity of in vitro transcribed 32P-labeled actin mRNA (as a
representative cellular RNA) in lysolecithin-treated cell-analyzed SIV mne (Benveniste et al., 1986; Agy et al.,
1991). For this purpose, we selected SIV mac251 origi- free extracts. Extracts were prepared from CEM cells
infected with HIV-1 LAI for 4 days and from mock-infectednally characterized by Derosiers and colleagues (Daniel
et al., 1985). Northern blot analysis was first performed cells. The extracts were prepared from cells which were
90% infected as determined by immunofluorescenceon total RNA from mock-infected cells and from cells
which were synchronously infected with HIV-1 at a high analysis and 85% viable as determined by trypan blue
staining. Radiolabeled actin mRNA was then incubatedmultiplicity of infection (Fig. 1A). As representative cellu-
lar mRNAs, we analyzed levels of actin and glyceralde- in these extracts for varying amounts of time, phenol
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FIG. 1. Northern blot analyses of total RNA prepared from HIV-1- and SIV-infected cells. (A) Northern blot analysis of actin and GAPDH cellular
mRNAs in mock- and HIV-1(LAI)-infected CEM cells. Total RNA (5 mg) was electrophoresed and blots analyzed after hybridization to 32P-labeled
probes. Days postinfection (p.i.) are indicated at the top. (B) Northern blot analysis of actin and GAPDH cellular mRNAs in mock-and SIV mac251-
infected CEMx174 cells. (C) Northern blot analysis of HIV viral RNAs in HIV-1-infected CEM cells. The blot shown in A was stripped and rehybridized
to a 32P-labeled full-length HIV-1 DNA probe. Position of major species of HIV RNAs are depicted by the arrows on the right. (D) Northern blot
analysis of SIV viral RNAs in SIV mac251-infected CEMx174 cells. The blot shown in B was stripped and rehybridized to a 32P-labeled full-length
SIV DNA probe. Position of major species of SIV RNAs are depicted by the arrows on the right.
extracted, ethanol precipitated, and analyzed on denatur- prepared extracts from another cell line, C8166 cells,
infected with HIV-1 for 3 days (Fig. 3). As was the caseing polyacrylamide gels (Fig. 2A). The data were subse-
quently quantitated by phosphorimager analysis (Fig. 2B). with CEM cells, we detected enhanced actin mRNA deg-
radation in virus-infected cell extracts. Degradation ofA representative experiment revealed that actin mRNA
decayed more rapidly during incubation in virus-infected actin mRNA in these extracts was nearly complete by 20
min of incubation. Nearly 100% of actin mRNA remainedCEM cell-free extracts than in extracts from uninfected
cells. After 5 hr of incubation in HIV-1-infected extracts, after incubation for this period of time in extracts from
uninfected C8166 cells.less than 30% of the actin RNA remained, while nearly
80% of actin mRNA remained after incubation in unin- Cellular mRNAs are not significantly degraded in ex-
tracts prepared from SIV-infected cells. We then at-fected extracts. It is noteworthy that we did not observe
discrete degradation products in these in vitro experi- tempted to examine RNA degradation in extracts pre-
pared from SIV-infected cells. For these experiments, wements. To confirm that this cell-free system induced the
viral-specific accelerated decay of cellular mRNA, we prepared extracts from CEMx174 cells which are readily
FIG. 2. In vitro assay analyzing the degradation of actin mRNA in HIV-1- and mock-infected CEM cell-free extracts. (A) An in vitro mRNA degradation
extract was prepared from mock-infected and HIV-1-infected CEM cells at 4 days postinfection as described under Materials and Methods. 32P-
labeled in vitro transcribed actin mRNA was added to the extracts and incubated at 307C. Samples were withdrawn at 0 hr (lanes 1, 6), 0.5 hr (lanes
2, 7), 1 hr (lanes 3, 8), 3 hr (lanes 4, 9), and 5 hr (lanes 5, 10). RNA was extracted from each sample as described under Materials and Methods
and analyzed on a 5% denaturing polyacrylamide gel. (B) The amounts of actin RNA (plotted as percentage RNA remaining vs time of incubation)
depicted in A was quantitated by phosphorimager analysis.
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1 compared to SIV-infected cell extracts. Although there
was somewhat more degradation in SIV-infected extracts
than in uninfected extracts in this experiment, we more
often found that cellular mRNA degradation in the two
extracts was minimal and indistinguishable as exempli-
fied by the experiment described below.
Analysis of the stability of mRNAs containing HIV-1
viral sequences. A question that our earlier in vivo analy-
sis was unable to answer was whether HIV-1 RNAs, like
cellular mRNAs, were degraded during viral infection. We
observed abundant accumulation of all major species of
HIV-1 RNAs, due to strong transcriptional activity off the
FIG. 3. In vitro assay analyzing the degradation of actin mRNA in highly active HIV-1 LTR. This made it difficult to detect
cell-free extracts prepared from HIV-1- and mock-infected C8166 cells.
any viral mRNA turnover that might occur. It is relevantPhosphorimager quantitation of radiolabeled actin RNA after an in vitro
to note that herpes simplex virus induces the degradationincubation with extracts prepared from mock- and HIV-1-infected C8166
cells at 3 days postinfection. of both cellular and viral mRNAs although it was originally
thought that only cellular mRNAs were degraded in HSV-
infected cells (reviewed in Katze and Agy, 1990). Withinfected by both the human and simian lentiviruses (Agy
the characterization of the vhs HSV mutant, it becameet al., 1990, 1991). Extracts were prepared from HIV-1-
evident that the virus induces the degradation of viralinfected cells at Day 3 and SIV-infected cells at Day 4,
mRNAs, thus providing a major control on viral genewhen approximately 95% of all cells were infected with
expression as well as cellular gene expression (Readthe respective lentiviruses. As with the extracts de-
and Frenkel, 1983; Oroskar and Read, 1989; Smibert etscribed above, there was extensive degradation of actin
al., 1992). To determine whether similar events were oc-mRNA in extracts prepared from HIV-1-infected CEMx174
curring in HIV-1-infected cells, the following set of experi-cells compared to extracts prepared from mock-infected
ments were performed. We first tested whether the TARcells and SIV-infected cells (Fig. 4A). Less than 10% of
(transactivating region) sequence, present at the 5* endactin mRNA remained after 30 min in vitro incubation
of all HIV-1 mRNAs (Rosen et al., 1985; Cullen, 1986),with HIV-1-infected extracts compared to approximately
conferred enhanced stability to a CAT reporter gene (Par-70% in SIV-infected extracts and nearly 100% remaining
kin et al., 1988). We reasoned that if all viral mRNAs werein mock-infected extracts (Fig. 4B). Approximately 45% of
resistant to the mRNA degradation, which occurred inactin mRNA remained after a 4-hr incubation with ex-
HIV-infected cells, such common sequences may confertracts from SIV-infected cells compared to 5% of actin
this resistance. We already determined that CAT mRNAmRNA remaining after incubation in HIV-1-infected cell
itself was efficiently degraded in HIV-1-infected extractsextracts and 70% of actin mRNA remaining after incuba-
(data not shown). TARCAT mRNA, containing nucleotidestion in mock-infected cell extracts. We reproducibly de-
tected accelerated degradation of cellular mRNA in HIV- 1–111 of the TAR region and the complete CAT coding
FIG. 4. Comparison of actin mRNA degradation in cell-free extracts prepared from HIV-1-, SIV-, and mock-infected CEMx174 cells. (A) An in vitro
mRNA degradation extract was prepared from mock-infected, SIV-infected, and HIV-1-infected CEMx174 cells as described under Materials and
Methods. 32P-labeled in vitro transcribed actin mRNA was added to the extracts and incubated at 307C. Samples were withdrawn at 0 hr (lanes 1,
5, 9), 0.5 hr (lanes 2, 6, 10), 1.5 hr (lanes 3, 7, 11), and 4 hr (lanes 4, 8, 12). RNA was extracted from each sample as described under Materials
and Methods and analyzed on a 5% denaturing polyacrylamide gel. (B) The amounts of actin RNA (plotted as percentage RNA remaining vs time
of incubation) depicted in A was quantitated by phosphorimager analysis.
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FIG. 5. Stability of TARCAT mRNA in cell-free extracts prepared from HIV-1-, SIV-, and mock-infected CEMx174 cells. (A) An in vitro mRNA
degradation extract was prepared from mock-infected, SIV-infected, and HIV-1-infected CEMx174 cells as described under Materials and Methods.
32P-labeled in vitro transcribed TARCAT RNA was added to the extracts and incubated at 307C. Samples were withdrawn at 0 hr (lanes 1, 5, 9), 0.5
hr (lanes 2, 6, 10), 1.5 hr (lanes 3, 7, 11), and 4 hr (lanes 4, 8, 12). RNA was extracted from each sample as described under Materials and Methods
and analyzed on a 5% denaturing polyacrylamide gel. (B) The amounts of TARCAT RNA (plotted as percentage RNA remaining vs time of incubation)
depicted in A was quantitated by phosphorimager analysis.
region (Parkin et al., 1988), was added to cell-free ex- thin treated HIV-1- and SIV-infected cells. Our goals were
tracts prepared from mock-infected, HIV-1-infected, and to reproduce events in vitro which occurred in vivo,
SIV-infected CEMx174 cells (Fig. 5A). Approximately 10% namely that cellular mRNAs were degraded in HIV-, but
of TARCAT mRNA remained after a 4-hr incubation in not in SIV-infected or uninfected cells. Utilizing extracts
HIV-1-infected extracts, while approximately 60% re- from detergent-treated CD4-positive cells infected by
mained in mock-infected extracts and 70% of the TARCAT HIV-1, we demonstrated that exogenously added 32P-la-
mRNA remained after incubation in SIV-infected cell-free beled actin RNA was degraded at an accelerated rate
extracts (Fig. 5B). These data, taken together, suggest compared to uninfected cell extracts. As was the case
that if viral mRNAs are indeed resistant to degradation, with our in vivo analysis (Agy et al., 1990, 1991), we did
sequences in addition to TAR region are necessary. not observe discrete cellular mRNA degradation prod-
These results also confirmed our earlier experiments ucts. Similar to our data, no specific RNA degradation
showing that mRNAs are not appreciably degraded in products were observed in cells infected by herpes sim-
extracts prepared from SIV-infected cells compared to plex viruses (Fenwick and Clark, 1982; Oroskar and
uninfected extracts. Read, 1989) or in HSV-infected cell-free extracts (Kriko-
In the final set of experiments, we examined the stabil- rian and Read, 1991; Sorenson et al., 1991), although
ity of a more bona fide HIV mRNA. A RNA expression such discrete products have been detected in other in
plasmid was constructed which contained HIV-1 se- vitro RNA degradation systems (Tanzer and Meagher,
quences from /1 within the TAR region through nucleo- 1994). It remains to be determined whether degradation
tide 684 within the gag region (referred to as TARGAG of cellular mRNAs in HIV-1-infected cells is due to dead-
mRNA). We then compared the stability of TARGAG enylation and/or decapping as observed in other eukary-
mRNA to actin mRNA in extracts prepared from HIV-1- otic systems (reviewed in Decker and Parker, 1994; Beel-
infected CEMx174 cells. The results, representative of man and Parker, 1995). It should be mentioned in this
three independent experiments, demonstrated that the regard, however, that the in vitro transcribed mRNAs in
TARGAG mRNA was more stable than the cellular actin the present study were not polyadenylated. We contend
mRNA throughout the 4-hr incubation period (Figs. 6A that the degradation observed in our in vitro system is
and 6B). For example, after a 1-hr incubation approxi- HIV-1 specific and would argue for three main reasons
mately 94% of TARGAG mRNA remained compared to that the observed mRNA decay in infected cell extracts
62% of actin mRNA; after a 4-hr incubation approximately is not merely due to activation of a nonspecific nuclease
65% of TARGAG mRNA remained compared to 25% of such as RNAse A. First, we included RNAsin, a RNAse
actin mRNA. Although these data are preliminary, it is A inhibitor, in all of our in vitro degradation reactions.
tempting to speculate that select HIV-1 mRNAs are, at
Second, we were able to prepare cell-free extracts from
least partially, resistant to the viral induced degradation
three separate cell lines infected by HIV-1 and demon-
of mRNAs.
strate accelerated degradation of actin RNA in all cell
DISCUSSION lines compared to mock-infected extracts, although the
extent of degradation appears to vary between the differ-In the present report we have established an in vitro
mRNA degradation assay utilizing extracts from lysoleci- ent cell lines for reasons that are currently unclear. Third,
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FIG. 6. Comparison of the stability of actin and TARGAG mRNAs in extracts prepared from HIV-1-infected CEMx174 cells. (A) An in vitro mRNA
degradation extract was prepared from HIV-1-infected CEMx174 cells as described under Materials and Methods. 32P-labeled in vitro transcribed
actin (lanes 1–4) or TARGAG RNA (lanes 5–8) was added to the extracts and incubated at 307C. Samples were withdrawn at 0 hr (lanes 1, 5), 1
hr (lanes 2, 6), 2 hr (lanes 3, 7), and 4 hr (lanes 4, 8). RNA was extracted from each sample as described under Materials and Methods and analyzed
on a 5% denaturing polyacrylamide gel. (B) The amounts of actin and TARGAG RNA (plotted as percentage RNA remaining vs time of incubation)
depicted in A was quantitated by phosphorimager analysis.
and most importantly, we would argue that if the results and Lengyel, 1992). In a related report, Schroder and
colleagues reported that the oligoadenylate synthetase-were due to viral-induced activation of a nonspecific ribo-
nuclease, we should have observed extensive RNA deg- RNAse L pathway may be responsible for viral RNA deg-
radation in HIV-infected cells (Schroder et al., 1989). Weradation in extracts prepared from SIV-infected cells. The
level of infection observed in both SIV- and HIV-1-infected have not, however, detected any significant degradation
of 18S and 28S ribosomal RNAs, often a major target ofcells under our experimental conditions was indistin-
guishable. In both cases, extracts were prepared in both RNAse L activity, in HIV-1-infected extracts, suggesting
that other ribonucleases may be involved in the degrada-cases when 95% of the cells were infected and 85%
of infected cells were viable. tion of cellular mRNAs.
The establishment of an in vitro mRNA degradationOne can only speculate as to the mechanisms respon-
sible for cellular mRNA degradation. A priority is to deter- assay should enable us to gain additional insights into
mechanisms of mRNA decay. It may allow us to deter-mine whether a viral gene product acts directly as a
nuclease or activates a cellular ribonuclease. Certainly, mine whether, as is the case with the herpes simplex
viruses, a viral structural component plays a role in thepossession of a mutant HIV-1, defective in inducing
mRNA degradation (such as the HSV vhs mutant), would ribonuclease pathway. Similarly, we would like to exam-
ine, in greater depth, the stability of specific viral mRNAs.help answer these questions. Further, It may be informa-
tive to test for mRNA degradation in cells infected by Our data indicate that while the TAR region (which is
present on all HIV-1 mRNAs) alone cannot confer resis-some of the newly described SIV-HIV (SHIV) chimeric
viruses to begin to identify responsible viral gene prod- tance to mRNA degradation, mRNAs containing HIV-1
sequences which include TAR and gag sequences mayucts (Li et al., 1992; Letvin et al., 1995). A candidate viral
gene product may be the HIV-1 regulatory gene product, be partially resistant to mRNA turnover in HIV-1-infected
cells. Our data therefore predict that not all species ofvpu, which is an integral membrane phosphoprotein
(Strebel et al., 1989; Willey et al., 1992; Maldarelli et al., viral mRNA will be stable in our extracts. As with other
eukaryotic viruses, HIV-1 gene expression can be divided1995; Schubert and Strebel, 1995). Thus far, however,
vpu has been shown to function only in the downmodula- into an early and late phase (Pavlakis and Felber, 1990;
Steffy and Wong-Staal, 1991). The early class of viraltion of CD4 and the enhancement of virion release (Willey
et al., 1992; reviewed in Trono, 1995). In regard to possi- mRNAs consist of the multiply spliced mRNAs encoding
the viral regulatory proteins while the late class ofble cellular nucleolytic pathways activated by HIV-1, Sil-
verman and co-workers have convincingly shown that mRNAs encode unspliced and singly spliced mRNAs that
encode virion structural proteins (Pavlakis and Felber,the HIV-1 TAR sequences have an intrinsic ability to acti-
vate the interferon-induced enzymes PKR and the 2–5 A 1990; Steffy and Wong-Staal, 1991). It is tempting to spec-
ulate that differential mRNA turnover may play a role insynthetase (Maitra et al., 1994). Both of these pathways
have been shown to be an integral part of the antiviral the regulation of HIV-1 gene expression in addition to
the other well understood transcriptional and post-tran-strategies of interferon, the latter inducing the degrada-
tion of mRNAs due to the activation of RNAse L (Sen scriptional mechanisms.
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